Definitive Contract 75N95021C00014
Award Date
9/20/21
Potential Completion Date
6/19/22
Potential Value
$332K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Cairn Biosciences Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Francisco, CA 94158, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
8
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Center for Advancing Translational Sciences, a civilian agency, to Cairn Biosciences Inc., a woman-owned small business. The contract, valued at $230,000.00, is for the development of a "Multifunctional, Reusable and Automated Microfluidic Smart Plate for High Throughput Live Cell Assays". The contract has a Firm Fixed Price pricing type and a period of performance ending on February...
<p>The National Center for Advancing Translational Sciences, a civilian agency, awarded a Firm Fixed Price definitive contract worth $225,000.00 to Cairn Biosciences Inc., a Woman Owned Small Business, for the development of a "MULTIPLEXED HIGH CONTENT ASSAY TO MEASURE ENDOPLASMIC RETICULUM STRESS FOR PREDICTIVE TOXICOLOGY". The contract has a total small business set-aside and is scheduled for completion by March 14, 2016.</p>
<p>This is a $229,893.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Cairn Biosciences Inc., a woman-owned small business. The contract is for the development of a "MULTIPLEXED HIGH CONTENT ASSAY FOR TOXICITY MECHANISMS AND PHENOTYPES IN LIVE IPSC-DERIVED CARDIAC CELLS." The contract is a definitive, firm-fixed price contract with a completion date of May 14, 2017.</p>
This is a $1,499,999.00 Firm Fixed Price contract awarded by the National Institute on Drug Abuse, a civilian agency, to Cairn Biosciences Inc., a woman-owned small business, for the development of a Multiplexed High-Content Assay to Measure Cellular Stress Mechanisms for Predictive Toxicology Studies. The contract was awarded under the SBIR Program Phase II and has a total small business set-aside designation. The contract was awarded on September 13, 2016 with an ultimate completion date of...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a Small Business Innovation Research (SBIR) Phase I contract to Gencirq, Inc., a for-profit organization, to develop a screening platform for therapeutics using a genetic lysis circuit. The firm-fixed-price contract has a potential value of $225,000.00 and a completion date of October 31, 2020. The contract was set aside for small businesses and is associated...
This Small Business Innovation Research (SBIR) Phase I contract, valued at $399,674, was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Inso Biosciences Inc., a small biotechnology startup. The contract supports the research and development of advanced sample processing platforms for downstream single-cell multi-omic analysis. This work aligns with the NIH and Centers for Disease Control and Prevention (CDC) mission to develop medical...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a firm fixed price purchase order to Caitta Inc., an SBA certified economically disadvantaged woman-owned small business, to provide a live cell analysis system. The potential value of the contract is $137,577.50, with a completion date of September 4, 2020. Caitta is an 8(a) program participant that has a history of providing scientific, technical, and administrative services to federal...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Advanced Silicon Group, Inc., a woman-owned small business. The contract, valued at $400,000.00, is for research and development of a biosensor prototype that can detect drugs in postmortem blood samples using coupled acoustical wave micropillar technology. The contract is a firm fixed-price definitive contract with a completion date of...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a Small Business Innovation Research (SBIR) Phase II contract to Mimetas US, Inc., a self-certified small disadvantaged business, to develop and evaluate the HEPAPLATE IPS, a high-throughput organ-on-a-chip in vitro hepatotoxicity screening platform. The $1,500,000.00 firm fixed price contract was awarded on February 8, 2018, with a completion date of...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Celartia, Inc., a small disadvantaged business, for the development of a fully automated system for cell therapy processing. The contract has a period of performance from September 13, 2021 to June 12, 2022 and a ceiling value of $393,312. The contract was awarded under a total small business set-aside. The original...